Emerging In Vitro Models for Safety Screening of High-Volume Production Nanomaterials under Environmentally Relevant Exposure Conditions

The rising production of nanomaterial‐based consumer products has raised safety concerns. Testing these with animal and other direct models is neither ethically nor economically viable, nor quick enough. This review aims to discuss the strength of in vitro testing, including the use of 2D and 3D cul...

Full description

Saved in:
Bibliographic Details
Published in:Small (Weinheim an der Bergstrasse, Germany) Germany), 2013-05, Vol.9 (9-10), p.1504-1520
Main Authors: Kathawala, Mustafa Hussain, Xiong, Sijing, Richards, Mark, Ng, Kee Woei, George, Saji, Loo, Say Chye Joachim
Format: Article
Language:English
Subjects:
3D cultures
Biocompatibility
Biomedical materials
Economics
Environmental Exposure
Humans
in vitro models
In vitro testing
In vivo testing
In vivo tests
Nanomaterials
nanosafety
Nanostructures
Nanotechnology
photoactive nanomaterials
stem cells
Stem Cells - drug effects
Surgical implants
Tissue Engineering
Toxicity Tests
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The rising production of nanomaterial‐based consumer products has raised safety concerns. Testing these with animal and other direct models is neither ethically nor economically viable, nor quick enough. This review aims to discuss the strength of in vitro testing, including the use of 2D and 3D cultures, stem cells, and tissue constructs, etc., which would give fast and repeatable answers of a highly specific nature, while remaining relevant to in vivo outcomes. These results can then be combined and the overall toxicity predicted with relative accuracy. Such in vitro models can screen potentially toxic nanomaterials which, if required, can undergo further stringent studies in animals. The cyto‐ and phototoxicity of some high‐volume production nanomaterials, using in vitro models, is also reviewed. In vivo assessment on the safety of nanomaterials, though the gold standard, is extremely resource intensive, thus rendering this approach economically unviable. Conventional in vitro models, though fast and highly economical, do not perfectly mimic real‐life situations. This review delves into emerging in vitro techniques that could bridge the gap between in vivo and in vivo studies, thereby balancing between resource usage and relevance to real‐life situations.
ISSN:1613-6810
1613-6829
DOI:10.1002/smll.201201452